رجوع
62
19
مُدرج أيضًا باسم
SKHHY
OTC
نطاق اليوم
KWD 15.00
KWD 15.00
نطاق 52 أسبوعًا
KWD 12.70
KWD 19.34
حجم التداول
180
متوسط 50 يوم / 200 يوم
KWD 14.99
/
KWD 15.85
الإغلاق السابق
KWD 15.00
تاريخ السعر
الاتجاهات المالية
مقارنة الأقران
مقابل وسيط قطاع Healthcare (627 نظير)
| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | 14.4 | 0.4 |
| P/B | 0.9 | 2.9 |
| ROE % | 6.3 | 3.9 |
| Net Margin % | 5.3 | 3.8 |
| Rev Growth 5Y % | 2.5 | 10.0 |
| D/E | 0.6 | 0.2 |
السعر المستهدف للمحللين
لا تتوفر تغطية محللين
تقديرات الأرباح
| الفترة | تقدير ربحية السهم | تقدير الإيرادات | المحللون |
|---|---|---|---|
| FY2029 |
KWD 1.691
KWD 1.639 – KWD 1.743
|
13 B | 1 |
| FY2028 |
KWD 1.574
KWD 1.526 – KWD 1.622
|
13 B | 1 |
| FY2027 |
KWD 1.449
KWD 1.405 – KWD 1.494
|
12 B | 1 |
النقاط الرئيسية
Revenue grew 2.45% annually over 5 years — modest growth
Generating 960.55M in free cash flow
P/E of 14.43 — trading at a low valuation
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 5.51%
Cash machine — converts 187.02% of earnings into free cash flow
Capital efficient — spends only 3.49% of revenue on capex
النمو
Revenue Growth (5Y)
2.45%
Revenue (1Y)7.96%
Earnings (1Y)0.49%
FCF Growth (3Y)-0.69%
الجودة
Return on Equity
6.32%
ROIC16.23%
Net Margin5.32%
Op. Margin30.28%
الأمان
Debt / Equity
0.62
Current Ratio1.17
Interest Coverage16.18
التقييم
P/E Ratio
14.43
P/B Ratio0.89
EV/EBITDA4.08
Dividend Yield0.04%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 7.96% | Revenue Growth (3Y) | 8.82% |
| Earnings Growth (1Y) | 0.49% | Earnings Growth (3Y) | -13.41% |
| Revenue Growth (5Y) | 2.45% | Earnings Growth (5Y) | -20.95% |
| Profitability | |||
| Revenue (TTM) | 9.65B | Net Income (TTM) | 513.60M |
| ROE | 6.32% | ROA | 3.20% |
| Gross Margin | 33.05% | Operating Margin | 30.28% |
| Net Margin | 5.32% | Free Cash Flow (TTM) | 960.55M |
| ROIC | 16.23% | FCF Growth (3Y) | -0.69% |
| Safety | |||
| Debt / Equity | 0.62 | Current Ratio | 1.17 |
| Interest Coverage | 16.18 | Dividend Yield | 0.04% |
| Valuation | |||
| P/E Ratio | 14.43 | P/B Ratio | 0.89 |
| P/S Ratio | 0.77 | PEG Ratio | 0.00 |
| EV/EBITDA | 4.08 | Dividend Yield | 0.04% |
| Market Cap | 7.41B | Enterprise Value | 11.91B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 9.65B | 8.93B | 8.14B | 9.34B | 8.75B |
| Net Income | 513.60M | 511.09M | 684.98M | 1.46B | 1.32B |
| EPS (Diluted) | 1.07 | 1.07 | 1.45 | 3.02 | 2.73 |
| Gross Profit | 3.19B | 7.48B | 6.87B | 7.74B | 3.43B |
| Operating Income | 2.92B | 2.69B | 2.63B | 3.52B | 3.18B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 16.05B | 14.83B | 13.56B | 12.55B | 11.76B |
| Total Liabilities | 7.58B | 6.75B | 5.64B | 5.12B | 5.26B |
| Shareholders' Equity | 8.32B | 7.92B | 7.74B | 7.27B | 6.38B |
| Total Debt | 5.17B | 4.52B | 3.10B | 3.01B | 3.23B |
| Cash & Equivalents | 673.77M | 645.00M | 797.99M | 780.00M | 899.83M |
| Current Assets | 2.61B | 2.35B | 2.13B | 2.31B | 2.28B |
| Current Liabilities | 2.22B | 2.32B | 1.88B | 2.08B | 2.22B |
درجات الاستراتيجيات
This stock passed the criteria for 2 strategies
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#199 of 1052
#467 of 618
النشاط الأخير
دخل
Cash Flow Compounder
Mar 24, 2026
دخل
Price/Sales Ratio Focus (Ken Fisher)
Mar 24, 2026